{
    "2018-09-04": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Vertex Inks Reimbursement Agreement for Orkambi in Australia",
                "features": {
                    "keywords": [
                        "Vertex",
                        "Reimbursement",
                        "Orkambi",
                        "Australia"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "These Monthly Dividend Stocks Are Set to Surge (and pay up to 6.8%)",
                "features": {
                    "keywords": [
                        "Monthly Dividend",
                        "Stocks",
                        "Surge",
                        "6.8%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Is Now a Good Time to Buy Gilead Sciences?",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Sciences",
                        "Buy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "AbbVie Reinforces Leadership in Dermatology With New Data Showcasing Research Advancements Across Growing Portfolio at the 27th European Academy of Dermatology and Venereology (EADV) Congress",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Dermatology",
                        "Research",
                        "Advancements",
                        "EADV"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}